本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bausch Health Companies Inc

5.97
-0.0750-1.24%
成交量:49.24萬
成交額:294.29萬
市值:22.10億
市盈率:14.20
高:6.04
開:5.95
低:5.93
收:6.04
52周最高:8.69
52周最低:4.25
股本:3.71億
流通股本:1.88億
量比:0.44
換手率:0.26%
股息:- -
股息率:- -
每股收益(TTM):0.4200
每股收益(LYR):0.4200
淨資產收益率:436.36%
總資產收益率:5.18%
市淨率:-3.99
市盈率(LYR):14.20

資料載入中...

公司資料

公司名字:
Bausch Health Companies Inc
交易所:
NYSE
成立時間:
- -
員工人數:
20300
公司地址:
2150 St. Elzéar Boulevard West,Laval,Quebec,Canada
郵編:
H7L 4A8
電話:
傳真:
- -
簡介:
Bausch Health Companies Inc.是一家在加拿大不列顛哥倫比亞省註冊的公司。該公司是一家跨國、專業製藥和醫療器械公司,主要在胃腸病學和皮膚病學的治療領域開發、製造和銷售一系列廣泛的品牌、非專利和品牌非專利藥品、非處方藥產品和醫療美容器械,並通過其對Bausch + Lomb Corporation約89%的所有權,在眼健康治療領域開發品牌和品牌非專利藥品、非處方藥產品和醫療器械(隱形眼鏡、人工晶狀體、眼科手術設備)。該公司的產品直接或間接銷往大約100個國家。

董事

名稱
職位
John A. Paulson
Chairman of the Board
Thomas J. Appio
Chief Executive Officer and Director
Amy B. Wechsler
Independent Director
Christian A. Garcia
Independent Director
Frank D. Lee
Independent Director
Richard C. Mulligan
Independent Director
Robert N. Power
Independent Director
Sarah B. Kavanagh
Independent Director
Michael Goettler
Director
Sandra Leung
Director

股東

名稱
職位
Thomas J. Appio
Chief Executive Officer and Director
Jean Jacques Charhon
Executive Vice President and Chief Financial Officer and Chief Accounting Officer
Steven Lee
Senior Vice President, Controller and Chief Accounting Officer
Aimee J. Lenar
Executive Vice President, US Pharma
Seana Carson
Executive Vice President and General Counsel